Skip Navigation

Hestia Insight Announces Health and Wellness Products E-vending Machine Pilot Program

LAS VEGAS, NV - (NewMediaWire) - July 20, 2022 - Hestia Insight Inc. (OTCQB: HSTA), a Company focused on the development and operation of novel technologies in the healthcare and biotech sectors, as well as providing sales and marketing guidance and capital markets advisory services to its clients, today announced that its wholly-owned subsidiary, HSTA HEALTH INC., purchased ten fully-automated HealthyYOU E-vending machines in connection with the Company’s vending pilot program.

The technologically advanced, unattended HealthyYOU E-vending machines dispense healthy food, beverage, and wellness products to paying customers at the point of sale, accepting cash, coin, credit or debit cards, and payments by smartphones, watches and other devices. The Company’s goal is to create a technology-driven health and wellness vending business division through its purchase and operation of the HealthyYOU vending machines.

Edward Lee, the Company’s CEO, stated, “Our recent initial purchase of HealthyYOU E-vending machines as part of our vending pilot program is a culmination of our extensive research into the healthy foods and wellness vending machine market and the evolution of healthy food and wellness technologies. The goal of our vending pilot program is to provide us with additional insights into this burgeoning market so we may participate in and contribute to its growth.  Subject to the outcomes of our vending pilot program, we intend to purchase and operate additional E-vending machines on an ongoing basis within our new vending business division.” 

Mr. Lee continued: “According to a March 1, 2022 article by, there are currently more than 6.9 million vending machines in the U.S., and the U.S. vending machine market size was $36.5 billion in 2020. We believe that the traditional vending machine business is ripe for change given the technological advances of E-vending machines and that people are more health conscious today.  Should our vending pilot program prove to be successful, we envision owning and operating thousands of E-vending machines in the coming years.”

About Hestia Insight Inc.  

Hestia Insight Inc. (“Hestia Insight” and the “Company”) is focused primarily on the healthcare and biotech sectors through the Company’s two wholly owned operating subsidiaries, Hestia Investments Inc. (“Hestia Investments”), and HSTA Health Inc. (“HSTA Health”). Hestia Investments provides strategic consulting, medical supply sales and marketing support, management, and capital markets advisory services for select micro, small and medium sized companies within the healthcare and biotech sectors. HSTA Health provides healthcare management and patient services and develops new healthcare technologies for neurological and psychiatric disorders. The Company is positioned to make strategic acquisitions of emerging growth companies with unique sciences and technologies. The Company intends to pursue the acquisition and development of healthcare related technologies in the healthcare and biotech sectors through acquisition, licensing, or joint ventures. The Company will also consider a third avenue of investing in certain technologies. The Company entered the healthcare sector to explore emerging healthcare technologies, especially growth companies that own and develop unique sciences and technologies.

For more information about Hestia Insight, please visit the Company’s website:

Hestia Insight Investor Relations:

Facebook: Hestia Insight Inc.

LinkedIn: Hestia Insight Inc.

Twitter: @HestiaInsight

Hestia Insight is subject to the information and reporting requirements of the Securities Exchange Act of 1934, as amended, and, in accordance with the Securities Exchange Act, the Company files periodic reports, documents, and other information with the SEC relating to our business, financial statements, and other matters. These filings are available to the public on the Commission’s website at

Safe Harbor Provision

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created thereby. All statements other than statements of historical fact contained herein, including, without limitation, statements regarding the Company's future financial position, business strategy, plans and objectives, growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates, are forward-looking statements.  Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expects," "intends," "plans," "projects," "estimates," "anticipates," or "believes" or the negative thereof or any variation thereon or similar terminology or expressions.  Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from results proposed in such statements.  Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can provide no assurance that such expectations will prove to have been correct.  Important factors that could cause actual results to differ materially from the Company's expectations include, but are not limited to, those factors set forth in the Company's Annual Report on Form 10-K for the year ended November 30, 2021 and its other filings and submissions with the SEC.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.  Except as required by law, the Company assumes no obligation to update or revise any forward-looking statements.

Investor Relations Contact:

Paul Knopick

Tel: 940.262.3584